SANUWAVE Health, Inc.
HealthcareNASDAQ:SNWV · NASDAQ Global Market
+$0.22 today
Vol 0.07M · Avg 0.09M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
729.6%
avg 160.6%
ROIC
19.4%
avg 155.7%
ROA
31.6%
avg -308.4%
Analysis
ROE is currently the strongest return metric at 729.6% versus its period average of 160.6%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Timothy Wern | Executive Vice President of Sales - U.S. Wound | $345,141.00 | — | 58 | $50,000.00 | 0.58% |
Peter Stegagno | Chief Regulatory Officer | $247,833.00 | — | 66 | $3,894.00 | 0.05% |
Daniel Coyle | Chief Operating Officer | $216,633.00 | — | 35 | — | — |
Morgan C. Frank | Chief Executive Officer & Chairman | $3,704.00 | — | 54 | $1,574.00 | 0.02% |
Christopher Cook | Chief Technology Officer | — | — | — | $212,030.00 | 2.47% |
Dustin Libby | Executive Vice President of Commercial Operations | — | — | — | — | — |
Peter Sorensen | Chief Financial Officer & Secretary | — | — | 33 | $3,894.00 | 0.05% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$38,360.96
Sells
17
$7.20M
Net Sentiment
$7.16M
Net selling
Most Active
Opaleye Management Inc.
12 transactions
1–10 of 18
Analysis
Insiders reported 1 buys worth $38,360.96 and 17 sells worth $7.20M over the last 12 months. That adds up to net selling of $7.16M. Opaleye Management Inc. was the most active insider with 12 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +7.9% | +23.2% (16yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +7.9% over three years. Forward estimates point to Revenue at +23.2% (16yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
908 Devices Inc.
NASDAQ:MASS
$312.72M
Senseonics Holdings, Inc.
NASDAQ:SENS
$299.93M
Sight Sciences, Inc.
NASDAQ:SGHT
$279.12M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$245.42M
Inogen, Inc.
NASDAQ:INGN
$173.28M
Immuneering Corporation
NASDAQ:IMRX
$152.11M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Solana Company
NASDAQ:HSDT
$89.92M
Outset Medical, Inc.
NASDAQ:OM
$83.23M
Who manages SNWV?
SANUWAVE Health, Inc. (SNWV) lists 7 active executives. The top listed executive is Christopher Cook, Chief Technology Officer.
Are SNWV insiders buying or selling?
Recent insider activity shows net buying of $41.15M.
Explore More
Continue the stock analysis
Jump to another research area for this company.